NEW YORK (Reuters Health) - Poor people are less likely to take part in clinical trials for new cancer drugs, which can make it harder to develop treatments, according to a new study. "Cancer clinical trials are how we move the field forward. As a result of patients not participating in clinical trials, it takes a lot longer and it's much more expensive to develop new therapies," said Dr. Dawn Hershman, who worked on the study. "In this study we found one factor that contributes to that is patient income," Hershman, from Columbia University in New York, told Reuters Health. ... via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment